Chase Brexton Health Services Diabetes Program
Chase Brexton Healthcare and UMB.
Date Funded: 2021 – 2023
Role: Principal Investigator
M-CERSI Collaborative Workshops – Collaborating to Advance Health Equity for Diabetes and Chronic Kidney Disease
MCERSI, UMB, and FDA.
Date Funded June 2020
Role: Principal Co-Investigator, Coordinator and Workshop Facilitator
Emocha Asthma Grant
Priority Partners MCO/University of Maryland/Emocha.
Date Funded: 2020 – 2021
Role: Principal Investigator
Emocha Diabetes Grant
University of Maryland Health Partners/University of Maryland/Emocha.
Date Funded: 2018 – 2020
Role: Co-investigator
Contraceptive Regulation Implementation: Stakeholder Facilitation [PI Charmaine Rochester-Eyeguokan]
Maryland Department of Health.
Date Funded: May 2017 – December 2018
Role Principal Investigator
Innovative Use of Patient Portals to Improve Medication Management and Adherence in Older Adults with Multiple Chronic Conditions: A Feasibility Study [Eun-Shim Nahm, C Diblasi]
University of Maryland School of Nursing.
Date Funded: March 2017 to March 2018 (University of Maryland School of Nursing)
Role Co-Investigator. Collaborative Grant (Feasibility Study)
Baltimore City Health Department (BCHD) and Center for Innovative Pharmacy Solutions (CIPS) Grant – Hypertension and Diabetes Screening in Baltimore City Community Pharmacies BCHD.
Date Funded: July to September 2017
Role: Principal Investigator
APMS Gaps in Diabetes Care Incentive Grant [Rochester CD; Grecheck L]
Alternative Payment Models Systems.
Date Funded: January 2017 – June 2017
Role: Principal Investigator: 10% Effort. Starter Grant; Creative Grant.
American Society of Health Systems Foundation Pharmacy Resident Practice-Based Research Grant Program Award [Rochester CD, Grecheck L]
Dates Funded: January 2017 – December 2017
Role: Senior Investigator: Charmaine Rochester. 20% Effort. Starter Grant; Creative Grant.
Pharmacist Intervention at Bay West Endocrinology Clinic [Rochester CD]
Sanofi Aventis Pharmaceuticals.
Dates Funded: January 2012 – January 2014
Role: Principal Investigator. 20% Effort. Full Grant. Creative Grant. Partnership with Bay West
Pharmacogenomics of CVD Risk Reduction: Shuldiner
National Institute of General Medical Sciences
Role: Other Significant Contributor. 5% Effort. Full Grant. Creative Grant.
The Metabolic Impact of Congenital Heterozygous ApoC-III Deficiency in Humans [Pollin] National Heart, Lung, and Blood Institutes – HL104193
Role: Other Significant Contributor. 4% Effort. Full Grant. Creative Grant.
Five Month Tobacco Cessation Partnership [Rochester CD]
Baltimore City. Partnership with Peoples Community Health Center.
Dates Funded: January 2009 – May 2009.
Role: Principal Investigator. 30% Effort. Full Grant. Creative Grant.
Collaborative Practice between the Center for Diabetes and Endocrinology Clinic and the University of Maryland School of Pharmacy. [Rochester CD]
University of Maryland Center for Diabetes and Endocrinology.
Dates Funded: 2008 – Current.
Role: Principal Investigator/Clinician. 10% Effort. Service Contract
The Pharmacogenomics of Thiazolidinedione Response – Pioglitazone Study DK074828 [Snitker] National Institutes of Diabetes & Digestive & kidney diseases
Role: Other Significant Contributor. 4% Effort. Full Grant. Creative Grant.